ezogabine has been researched along with Channelopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gautier, NM; Glasscock, E; Mishra, V; Vanhoof-Villalba, SL | 1 |
| Legido, A; Valencia, I; Walleigh, DJ | 1 |
| Lerche, H; Maljevic, S; Seebohm, G; Wuttke, TV | 1 |
1 review(s) available for ezogabine and Channelopathies
| Article | Year |
|---|---|
KV7 channelopathies.
Topics: Animals; Carbamates; Channelopathies; Epilepsy; Humans; KCNQ Potassium Channels; Long QT Syndrome; Mutation; Phenylenediamines | 2010 |
2 other study(ies) available for ezogabine and Channelopathies
| Article | Year |
|---|---|
Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy.
Topics: Animals; Anticonvulsants; Atrioventricular Block; Behavior, Animal; Bradycardia; Carbamates; Channelopathies; Death, Sudden; Disease Models, Animal; Drug Resistance; Drug Resistant Epilepsy; Electroencephalography; Epilepsy; Gene Expression Profiling; Heart Rate; KCNQ Potassium Channels; KCNQ1 Potassium Channel; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Kv1.1 Potassium Channel; Mice; Nerve Tissue Proteins; Pharmacogenetics; Pharmacogenomic Testing; Phenylenediamines; RNA, Messenger; Transcriptome | 2018 |
Ring chromosome 20: a pediatric potassium channelopathy responsive to treatment with ezogabine.
Topics: Anticonvulsants; Carbamates; Channelopathies; Child; Chromosomes, Human, Pair 20; Female; Humans; Phenylenediamines; Potassium Channels; Ring Chromosomes | 2013 |